Clinical Research Institute of Southern Oregon

Clinical Research Institute of Southern Oregon (CRISO) is a specialized clinical research site based in Medford, Oregon, focusing on Phase 1 through Phase 4 clinical trials. Founded in 1998 by Dr. Edward Kerwin, the institute has established a national reputation for excellence in respiratory, allergy, and immunology research. The facility operates as a high-volume enrollment site for major pharmaceutical and biotechnology sponsors, leveraging a sophisticated patient database and specialized diagnostic capabilities. In 2022, CRISO was acquired by Velocity Clinical Research, integrating the site into one of the world's largest networks of fully integrated clinical research sites. The institute continues to provide comprehensive trial management services, contributing to the development of numerous FDA-approved therapies for asthma, allergies, and infectious diseases.